ArticleACS medicinal chemistry letters2025

Novel Isoxazolidines Derivatives as RIPK1 Inhibitors for Treating Neurodegenerative Diseases.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.